| Full sample | Paper | Web | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | Respondents | Adj. RR2 | 95% CI | P | Respondents | Adj. RR2 | 95% CI | P | |||
n | Col.% | n | Col.% | n | Col.% | |||||||
Time since diagnosis | ||||||||||||
 Long-term | 192 | 43.0 | 43 | 37.7 | 1.00 | Ref. |  | 35 | 36.8 | 1.00 | Ref. |  |
 Short-term | 254 | 57.0 | 71 | 62.3 | 1.36 | 1.01, 1.84 | 0.043 | 60 | 63.2 | 1.07 | 0.74, 1.54 | 0.719 |
Sex | ||||||||||||
 Female | 252 | 56.5 | 74 | 64.9 | 1.39 | 0.91, 2.12 | 0.127 | 52 | 54.7 | 0.75 | 0.46, 1.22 | 0.249 |
 Male | 194 | 43.5 | 40 | 35.1 | 1.00 | Ref. |  | 43 | 45.3 | 1.00 | Ref. |  |
Current age | ||||||||||||
  < 40 | 74 | 16.6 | 14 | 12.3 | 1.00 | Ref. |  | 13 | 13.7 | 1.00 | Ref. |  |
 40–49 | 126 | 28.3 | 34 | 29.8 | 1.34 | 0.83, 2.16 | 0.238 | 30 | 31.6 | 1.49 | 0.86, 2.59 | 0.157 |
 50–59 | 171 | 38.3 | 40 | 35.1 | 1.67 | 0.99, 2.80 | 0.053 | 34 | 35.8 | 1.06 | 0.59, 1.89 | 0.856 |
  > =60 | 75 | 16.8 | 26 | 22.8 | 1.78 | 1.02, 3.06 | 0.043 | 18 | 19.0 | 1.56 | 0.80, 3.06 | 0.196 |
Race | ||||||||||||
 White | 416 | 93.3 | 108 | 94.7 | 1.00 | Ref. |  | 92 | 96.8 | 1.00 | Ref. |  |
 Nonwhite | 30 | 6.7 | 6 | 5.3 | 0.76 | 0.41, 1.41 | 0.379 | < 53 | – | 0.45 | 0.16, 1.29 | 0.138 |
Ethnicity | ||||||||||||
 Hispanic | 68 | 15.5 | 15 | 13.4 | 0.90 | 0.60, 1.35 | 0.611 | 8 | 8.5 | 0.51 | 0.27, 0.96 | 0.036 |
 Non-Hispanic | 372 | 84.6 | 97 | 86.6 | 1.00 | Ref. |  | 86 | 91.5 | 1.00 | Ref. |  |
Geography | ||||||||||||
 Rural | 61 | 13.7 | 19 | 16.7 | 0.84 | 0.57, 1.21 | 0.347 | 10 | 10.5 | 0.91 | 0.55, 1.51 | 0.728 |
 Metropolitan | 385 | 86.3 | 95 | 83.3 | 1.00 | Ref. |  | 85 | 89.5 | 1.00 | Ref. |  |
Cancer site | ||||||||||||
 Colorectal | 128 | 28.7 | 26 | 22.8 | 1.00 | Ref. |  | 25 | 26.3 | 1.00 | Ref. |  |
 Myeloma | 64 | 14.4 | 20 | 17.5 | 1.45 | 0.77, 2.73 | 0.256 | 13 | 13.7 | 0.78 | 0.40, 1.54 | 0.480 |
 Breast | 97 | 21.8 | 27 | 23.7 | 0.92 | 0.57, 1.50 | 0.745 | 19 | 20.0 | 1.18 | 0.63, 2.21 | 0.597 |
 Ovarian | 63 | 14.1 | 21 | 18.4 | 1.26 | 0.79, 2.03 | 0.334 | 16 | 16.8 | 1.51 | 0.85, 2.68 | 0.157 |
 Prostate | 94 | 21.1 | 20 | 17.5 | 0.89 | 0.51, 1.56 | 0.687 | 22 | 23.2 | 1.22 | 0.72, 2.04 | 0.459 |
Stage | ||||||||||||
 In situ | 24 | 5.4 | 7 | 6.1 | 1.00 | Ref. |  | 7 | 7.4 | 1.00 | Ref. |  |
 Localized | 211 | 47.3 | 54 | 47.4 | 0.76 | 0.44, 1.30 | 0.313 | 39 | 41.1 | 0.74 | 0.37, 1.46 | 0.383 |
 Regional | 114 | 25.6 | 23 | 20.2 | 0.60 | 0.34, 1.07 | 0.086 | 26 | 27.4 | 0.86 | 0.43, 1.71 | 0.667 |
 Distant | 97 | 21.8 | 30 | 26.3 | 0.59 | 0.28, 1.21 | 0.149 | 23 | 24.2 | 1.11 | 0.52, 2.39 | 0.786 |